Why would Adam F not mention anything about NDA by Japan?
Of the $7,000,000 $ USA payment to Keryx or the Compassion extensions allowed to patients in the study. Surely this would have been important facts other than his projections about Keryx? Surely, these would point to factual success and not gut feelings? They were wrong with several drugs projections on release, only time will tell on sales of Zerenex.